WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000061068) ANTHELMINTIC COMPOSITIONS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/061068    International Application No.:    PCT/NZ2000/000053
Publication Date: 19.10.2000 International Filing Date: 14.04.2000
Chapter 2 Demand Filed:    13.09.2000    
IPC:
A61K 9/00 (2006.01), A61K 31/4184 (2006.01), A61K 31/70 (2006.01), A61K 45/06 (2006.01)
Applicants: ASHMONT HOLDINGS LIMITED [NZ/NZ]; 48 Diana Drive, Glenfield, Auckland 1310 (NZ) (For All Designated States Except US).
COLIN, Manson, Harvey [NZ/NZ]; (NZ) (For US Only)
Inventors: COLIN, Manson, Harvey; (NZ)
Agent: PIPER, James, William; Piper Knowles, P.O. Box 5298, Wellesley Street, Auckland 1036 (NZ)
Priority Data:
335166 14.04.1999 NZ
Title (EN) ANTHELMINTIC COMPOSITIONS
(FR) COMPOSITION ANTHELMINTIQUE
Abstract: front page image
(EN)The invention relates to a novel formulation having the advantage of including triclabendazole in solution. In addition a further anthelmintic may be included. The formulation is made by mixing the abamectin and benzyl alcohol and mixing this with triclabendazole and butyl dioxitol. The mix is then heated to dissolve the active, and allowed to cool at which stage the solution is diluted to volume with PEG 4000. The present invention overcomes the solubility difficulties of triclabendazole and presents the triclabendazole in a solution.
(FR)The invention relates to a novel formulation having the advantage of including triclabendazole in solution. In addition a further anthelmintic may be included. The formulation is made by mixing the abamectin and benzyl alcohol and mixing this with triclabendazole and butyl dioxitol. The mix is then heated to dissolve the active, and allowed to cool at which stage the solution is diluted to volume with PEG 4000. The present invention overcomes the solubility difficulties of triclabendazole and presents the triclabendazole in a solution.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)